Global Inactivated Vaccine Sales Market Report 2017

世界の不活化ワクチン市場:販売動向2017

◆タイトル:Global Inactivated Vaccine Sales Market Report 2017
◆商品コード:QYR70322242
◆調査・発行会社:QYResearch
◆発行日:2017年2月20日
◆ページ数:106
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
Enterprise(全社内共有可)USD8,000 ⇒換算¥904,000見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearchの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、不活化ワクチンの世界市場について調査・分析し、不活化ワクチンのメーカー別販売量、市場シェア分析、種類別販売分析、用途別販売分析、地域別販売分析(アメリカ、中国、ヨーロッパ、日本、東南アジア、インド)、価格動向、企業動向、不活化ワクチン産業チェーン分析、世界市場規模予測などを含め、以下の構成でお届けいたします。

・不活化ワクチン市場概要
・不活化ワクチンのメーカー別販売量・メーカー別シェア
・不活化ワクチンの世界市場:種類別販売量・市場シェア
・不活化ワクチンの世界市場:用途別販売量・市場シェア
・不活化ワクチンの世界市場:地域別販売量・市場シェア
・不活化ワクチンのアメリカ市場規模
・不活化ワクチンの中国市場規模
・不活化ワクチンのヨーロッパ市場規模
・不活化ワクチンの日本市場規模
・不活化ワクチンの東南アジア市場規模
・不活化ワクチンのインド市場規模
・不活化ワクチンのメーカー別分析(企業概要、事業概要、商品概要、収益、価格等)
・不活化ワクチンのコスト分析・価格動向
・不活化ワクチンの産業チェーン(サプライチェーン分析)
・不活化ワクチンのマーケティング戦略・販売チャネル、流通業者
・不活化ワクチン市場への影響要因分析
・不活化ワクチンの世界市場予測
・不活化ワクチンのアメリカ市場予測
・不活化ワクチンの中国市場予測
・不活化ワクチンのヨーロッパ市場予測
・不活化ワクチンの日本市場予測
・不活化ワクチンの東南アジア市場予測
・不活化ワクチンのインド市場予測
・不活化ワクチンの種類別世界市場予測
・不活化ワクチンの用途別世界市場予測
...

Notes:Sales, means the sales volume of Inactivated Vaccine
Revenue, means the sales value of Inactivated Vaccine

This report studies sales (consumption) of Inactivated Vaccine in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering
Astellas Pharma Inc
CSL Limited
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Merck
Pfizer

Market Segment by Regions, this report splits Global into several key Regions, with sales (consumption), revenue, market share and growth rate of Inactivated Vaccine in these regions, from 2011 to 2021 (forecast), like
United States
China
Europe
Japan
Southeast Asia
India
Split by product Types, with sales, revenue, price and gross margin, market share and growth rate of each type, can be divided into
Type I
Type II
Split by applications, this report focuses on sales, market share and growth rate of Inactivated Vaccine in each application, can be divided into
Application 1
Application 2

【レポートの目次】

Table of Contents

Global Inactivated Vaccine Sales Market Report 2017
1 Inactivated Vaccine Overview
1.1 Product Overview and Scope of Inactivated Vaccine
1.2 Classification of Inactivated Vaccine
1.2.1 Type I
1.2.2 Type II
1.3 Application of Inactivated Vaccine
1.3.1 Application 1
1.3.2 Application 2
1.4 Inactivated Vaccine Market by Regions
1.4.1 United States Status and Prospect (2012-2022)
1.4.2 China Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 Japan Status and Prospect (2012-2022)
1.4.5 Southeast Asia Status and Prospect (2012-2022)
1.4.6 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value and Volume) of Inactivated Vaccine (2012-2022)
1.5.1 Global Inactivated Vaccine Sales and Growth Rate (2012-2022)
1.5.2 Global Inactivated Vaccine Revenue and Growth Rate (2012-2022)

2 Global Inactivated Vaccine Competition by Manufacturers, Type and Application
2.1 Global Inactivated Vaccine Market Competition by Manufacturers
2.1.1 Global Inactivated Vaccine Sales and Market Share of Key Manufacturers (2012-2017)
2.1.2 Global Inactivated Vaccine Revenue and Share by Manufacturers (2012-2017)
2.2 Global Inactivated Vaccine (Volume and Value) by Type
2.2.1 Global Inactivated Vaccine Sales and Market Share by Type (2012-2017)
2.2.2 Global Inactivated Vaccine Revenue and Market Share by Type (2012-2017)
2.3 Global Inactivated Vaccine (Volume and Value) by Regions
2.3.1 Global Inactivated Vaccine Sales and Market Share by Regions (2012-2017)
2.3.2 Global Inactivated Vaccine Revenue and Market Share by Regions (2012-2017)
2.4 Global Inactivated Vaccine (Volume) by Application

3 United States Inactivated Vaccine (Volume, Value and Sales Price)
3.1 United States Inactivated Vaccine Sales and Value (2012-2017)
3.1.1 United States Inactivated Vaccine Sales and Growth Rate (2012-2017)
3.1.2 United States Inactivated Vaccine Revenue and Growth Rate (2012-2017)
3.1.3 United States Inactivated Vaccine Sales Price Trend (2012-2017)
3.2 United States Inactivated Vaccine Sales and Market Share by Manufacturers
3.3 United States Inactivated Vaccine Sales and Market Share by Type
3.4 United States Inactivated Vaccine Sales and Market Share by Application

4 China Inactivated Vaccine (Volume, Value and Sales Price)
4.1 China Inactivated Vaccine Sales and Value (2012-2017)
4.1.1 China Inactivated Vaccine Sales and Growth Rate (2012-2017)
4.1.2 China Inactivated Vaccine Revenue and Growth Rate (2012-2017)
4.1.3 China Inactivated Vaccine Sales Price Trend (2012-2017)
4.2 China Inactivated Vaccine Sales and Market Share by Manufacturers
4.3 China Inactivated Vaccine Sales and Market Share by Type
4.4 China Inactivated Vaccine Sales and Market Share by Application

5 Europe Inactivated Vaccine (Volume, Value and Sales Price)
5.1 Europe Inactivated Vaccine Sales and Value (2012-2017)
5.1.1 Europe Inactivated Vaccine Sales and Growth Rate (2012-2017)
5.1.2 Europe Inactivated Vaccine Revenue and Growth Rate (2012-2017)
5.1.3 Europe Inactivated Vaccine Sales Price Trend (2012-2017)
5.2 Europe Inactivated Vaccine Sales and Market Share by Manufacturers
5.3 Europe Inactivated Vaccine Sales and Market Share by Type
5.4 Europe Inactivated Vaccine Sales and Market Share by Application

6 Japan Inactivated Vaccine (Volume, Value and Sales Price)
6.1 Japan Inactivated Vaccine Sales and Value (2012-2017)
6.1.1 Japan Inactivated Vaccine Sales and Growth Rate (2012-2017)
6.1.2 Japan Inactivated Vaccine Revenue and Growth Rate (2012-2017)
6.1.3 Japan Inactivated Vaccine Sales Price Trend (2012-2017)
6.2 Japan Inactivated Vaccine Sales and Market Share by Manufacturers
6.3 Japan Inactivated Vaccine Sales and Market Share by Type
6.4 Japan Inactivated Vaccine Sales and Market Share by Application
7 Southeast Asia Inactivated Vaccine (Volume, Value and Sales Price)
7.1 Southeast Asia Inactivated Vaccine Sales and Value (2012-2017)
7.1.1 Southeast Asia Inactivated Vaccine Sales and Growth Rate (2012-2017)
7.1.2 Southeast Asia Inactivated Vaccine Revenue and Growth Rate (2012-2017)
7.1.3 Southeast Asia Inactivated Vaccine Sales Price Trend (2012-2017)
7.2 Southeast Asia Inactivated Vaccine Sales and Market Share by Manufacturers
7.3 Southeast Asia Inactivated Vaccine Sales and Market Share by Type
7.4 Southeast Asia Inactivated Vaccine Sales and Market Share by Application
8 India Inactivated Vaccine (Volume, Value and Sales Price)
8.1 India Inactivated Vaccine Sales and Value (2012-2017)
8.1.1 India Inactivated Vaccine Sales and Growth Rate (2012-2017)
8.1.2 India Inactivated Vaccine Revenue and Growth Rate (2012-2017)
8.1.3 India Inactivated Vaccine Sales Price Trend (2012-2017)
8.2 India Inactivated Vaccine Sales and Market Share by Manufacturers
8.3 India Inactivated Vaccine Sales and Market Share by Type
8.4 India Inactivated Vaccine Sales and Market Share by Application

9 Global Inactivated Vaccine Manufacturers Analysis
9.1 Astellas Pharma Inc
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Inactivated Vaccine Product Type, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Astellas Pharma Inc Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.1.4 Main Business/Business Overview
9.2 CSL Limited
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Inactivated Vaccine Product Type, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 CSL Limited Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.2.4 Main Business/Business Overview
9.3 Emergent BioSolutions
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Inactivated Vaccine Product Type, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Emergent BioSolutions Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.3.4 Main Business/Business Overview
9.4 GlaxoSmithKline
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Inactivated Vaccine Product Type, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 GlaxoSmithKline Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.4.4 Main Business/Business Overview
9.5 Johnson & Johnson
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Inactivated Vaccine Product Type, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Johnson & Johnson Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.5.4 Main Business/Business Overview
9.6 MedImmune
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Inactivated Vaccine Product Type, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 MedImmune Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.6.4 Main Business/Business Overview
9.7 Merck
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Inactivated Vaccine Product Type, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 Merck Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.7.4 Main Business/Business Overview
9.8 Pfizer
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Inactivated Vaccine Product Type, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 Pfizer Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
9.8.4 Main Business/Business Overview

10 Inactivated Vaccine Maufacturing Cost Analysis
10.1 Inactivated Vaccine Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Inactivated Vaccine
10.3 Manufacturing Process Analysis of Inactivated Vaccine

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Inactivated Vaccine Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Inactivated Vaccine Major Manufacturers in 2015
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Inactivated Vaccine Market Forecast (2017-2022)
14.1 Global Inactivated Vaccine Sales, Revenue and Price Forecast (2017-2022)
14.1.1 Global Inactivated Vaccine Sales and Growth Rate Forecast (2017-2022)
14.1.2 Global Inactivated Vaccine Revenue and Growth Rate Forecast (2017-2022)
14.1.3 Global Inactivated Vaccine Price and Trend Forecast (2017-2022)
14.2 Global Inactivated Vaccine Sales, Revenue and Growth Rate Forecast by Regions (2017-2022)
14.2.1 United States Inactivated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.2 China Inactivated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.3 Europe Inactivated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.4 Japan Inactivated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.5 Southeast Asia Inactivated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.2.6 India Inactivated Vaccine Sales, Revenue and Growth Rate Forecast (2017-2022)
14.3 Global Inactivated Vaccine Sales, Revenue and Price Forecast by Type (2017-2022)
14.4 Global Inactivated Vaccine Sales Forecast by Application (2017-2022)

15 Research Findings and Conclusion

16 Appendix
Methodology
Analyst Introduction
Data Source

List of Tables and Figures

Figure Picture of Inactivated Vaccine
Table Classification of Inactivated Vaccine
Figure Global Sales Market Share of Inactivated Vaccine by Type in 2015
Figure Type I Picture
Figure Type II Picture
Table Applications of Inactivated Vaccine
Figure Global Sales Market Share of Inactivated Vaccine by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure United States Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Figure China Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Figure Europe Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Figure Japan Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Figure Southeast Asia Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Figure India Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Figure Global Inactivated Vaccine Sales and Growth Rate (2012-2022)
Figure Global Inactivated Vaccine Revenue and Growth Rate (2012-2022)
Table Global Inactivated Vaccine Sales of Key Manufacturers (2012-2017)
Table Global Inactivated Vaccine Sales Share by Manufacturers (2012-2017)
Figure 2015 Inactivated Vaccine Sales Share by Manufacturers
Figure 2016 Inactivated Vaccine Sales Share by Manufacturers
Table Global Inactivated Vaccine Revenue by Manufacturers (2012-2017)
Table Global Inactivated Vaccine Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Inactivated Vaccine Revenue Share by Manufacturers
Table 2016 Global Inactivated Vaccine Revenue Share by Manufacturers
Table Global Inactivated Vaccine Sales and Market Share by Type (2012-2017)
Table Global Inactivated Vaccine Sales Share by Type (2012-2017)
Figure Sales Market Share of Inactivated Vaccine by Type (2012-2017)
Figure Global Inactivated Vaccine Sales Growth Rate by Type (2012-2017)
Table Global Inactivated Vaccine Revenue and Market Share by Type (2012-2017)
Table Global Inactivated Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Inactivated Vaccine by Type (2012-2017)
Figure Global Inactivated Vaccine Revenue Growth Rate by Type (2012-2017)
Table Global Inactivated Vaccine Sales and Market Share by Regions (2012-2017)
Table Global Inactivated Vaccine Sales Share by Regions (2012-2017)
Figure Sales Market Share of Inactivated Vaccine by Regions (2012-2017)
Figure Global Inactivated Vaccine Sales Growth Rate by Regions (2012-2017)
Table Global Inactivated Vaccine Revenue and Market Share by Regions (2012-2017)
Table Global Inactivated Vaccine Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Inactivated Vaccine by Regions (2012-2017)
Figure Global Inactivated Vaccine Revenue Growth Rate by Regions (2012-2017)
Table Global Inactivated Vaccine Sales and Market Share by Application (2012-2017)
Table Global Inactivated Vaccine Sales Share by Application (2012-2017)
Figure Sales Market Share of Inactivated Vaccine by Application (2012-2017)
Figure Global Inactivated Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Inactivated Vaccine Sales and Growth Rate (2012-2017)
Figure United States Inactivated Vaccine Revenue and Growth Rate (2012-2017)
Figure United States Inactivated Vaccine Sales Price Trend (2012-2017)
Table United States Inactivated Vaccine Sales by Manufacturers (2012-2017)
Table United States Inactivated Vaccine Market Share by Manufacturers (2012-2017)
Table United States Inactivated Vaccine Sales by Type (2012-2017)
Table United States Inactivated Vaccine Market Share by Type (2012-2017)
Table United States Inactivated Vaccine Sales by Application (2012-2017)
Table United States Inactivated Vaccine Market Share by Application (2012-2017)
Figure China Inactivated Vaccine Sales and Growth Rate (2012-2017)
Figure China Inactivated Vaccine Revenue and Growth Rate (2012-2017)
Figure China Inactivated Vaccine Sales Price Trend (2012-2017)
Table China Inactivated Vaccine Sales by Manufacturers (2012-2017)
Table China Inactivated Vaccine Market Share by Manufacturers (2012-2017)
Table China Inactivated Vaccine Sales by Type (2012-2017)
Table China Inactivated Vaccine Market Share by Type (2012-2017)
Table China Inactivated Vaccine Sales by Application (2012-2017)
Table China Inactivated Vaccine Market Share by Application (2012-2017)
Figure Europe Inactivated Vaccine Sales and Growth Rate (2012-2017)
Figure Europe Inactivated Vaccine Revenue and Growth Rate (2012-2017)
Figure Europe Inactivated Vaccine Sales Price Trend (2012-2017)
Table Europe Inactivated Vaccine Sales by Manufacturers (2012-2017)
Table Europe Inactivated Vaccine Market Share by Manufacturers (2012-2017)
Table Europe Inactivated Vaccine Sales by Type (2012-2017)
Table Europe Inactivated Vaccine Market Share by Type (2012-2017)
Table Europe Inactivated Vaccine Sales by Application (2012-2017)
Table Europe Inactivated Vaccine Market Share by Application (2012-2017)
Figure Japan Inactivated Vaccine Sales and Growth Rate (2012-2017)
Figure Japan Inactivated Vaccine Revenue and Growth Rate (2012-2017)
Figure Japan Inactivated Vaccine Sales Price Trend (2012-2017)
Table Japan Inactivated Vaccine Sales by Manufacturers (2012-2017)
Table Japan Inactivated Vaccine Market Share by Manufacturers (2012-2017)
Table Japan Inactivated Vaccine Sales by Type (2012-2017)
Table Japan Inactivated Vaccine Market Share by Type (2012-2017)
Table Japan Inactivated Vaccine Sales by Application (2012-2017)
Table Japan Inactivated Vaccine Market Share by Application (2012-2017)
Figure Southeast Asia Inactivated Vaccine Sales and Growth Rate (2012-2017)
Figure Southeast Asia Inactivated Vaccine Revenue and Growth Rate (2012-2017)
Figure Southeast Asia Inactivated Vaccine Sales Price Trend (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales by Manufacturers (2012-2017)
Table Southeast Asia Inactivated Vaccine Market Share by Manufacturers (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales by Type (2012-2017)
Table Southeast Asia Inactivated Vaccine Market Share by Type (2012-2017)
Table Southeast Asia Inactivated Vaccine Sales by Application (2012-2017)
Table Southeast Asia Inactivated Vaccine Market Share by Application (2012-2017)
Figure India Inactivated Vaccine Sales and Growth Rate (2012-2017)
Figure India Inactivated Vaccine Revenue and Growth Rate (2012-2017)
Figure India Inactivated Vaccine Sales Price Trend (2012-2017)
Table India Inactivated Vaccine Sales by Manufacturers (2012-2017)
Table India Inactivated Vaccine Market Share by Manufacturers (2012-2017)
Table India Inactivated Vaccine Sales by Type (2012-2017)
Table India Inactivated Vaccine Market Share by Type (2012-2017)
Table India Inactivated Vaccine Sales by Application (2012-2017)
Table India Inactivated Vaccine Market Share by Application (2012-2017)
Table Astellas Pharma Inc Basic Information List
Table Astellas Pharma Inc Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Astellas Pharma Inc Inactivated Vaccine Global Market Share (2012-2017)
Table CSL Limited Basic Information List
Table CSL Limited Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure CSL Limited Inactivated Vaccine Global Market Share (2012-2017)
Table Emergent BioSolutions Basic Information List
Table Emergent BioSolutions Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Emergent BioSolutions Inactivated Vaccine Global Market Share (2012-2017)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Inactivated Vaccine Global Market Share (2012-2017)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Johnson & Johnson Inactivated Vaccine Global Market Share (2012-2017)
Table MedImmune Basic Information List
Table MedImmune Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure MedImmune Inactivated Vaccine Global Market Share (2012-2017)
Table Merck Basic Information List
Table Merck Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Merck Inactivated Vaccine Global Market Share (2012-2017)
Table Pfizer Basic Information List
Table Pfizer Inactivated Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inactivated Vaccine Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Inactivated Vaccine
Figure Manufacturing Process Analysis of Inactivated Vaccine
Figure Inactivated Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Inactivated Vaccine Major Manufacturers in 2015
Table Major Buyers of Inactivated Vaccine
Table Distributors/Traders List
Figure Global Inactivated Vaccine Sales and Growth Rate Forecast (2017-2022)
Figure Global Inactivated Vaccine Revenue and Growth Rate Forecast (2017-2022)
Table Global Inactivated Vaccine Sales Forecast by Regions (2017-2022)
Table Global Inactivated Vaccine Sales Forecast by Type (2017-2022)
Table Global Inactivated Vaccine Sales Forecast by Application (2017-2022)



【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界の不活化ワクチン市場:販売動向2017] (Global Inactivated Vaccine Sales Market Report 2017 / QYR70322242)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆